Carotid Artery Diseases - 26 Studies Found
Completed |
: Carotid With Bivalirudin Angioplasty : Carotid Artery Disease : 2008-12-18 : Device: RX ACCULINK™ Carotid Stent System; RX ACCUNET™ Embolic Protection System; PercuSurge GuardWire® 3-6 Temporary Occlusion and A |
Terminated |
: Feasibility Study of Simvastatin in Hodgkin's Lymphoma Survivors : Carotid Artery Disease : 2008-09-02 : Drug: Simvastatin All patients will start at 10mg of simvastatin, and then, based on results of interim |
Completed |
: Proximal Protection With The Mo.Ma Device During Carotid Stenting : Carotid Artery Disease : 2008-08-29 : Device: Mo.Ma cerebral protection device Proximal embolic protection based on the principle endovascular |
Completed |
: A Carotid Stenting Boston Scientific Surveillance Program : Carotid Artery Disease : 2008-08-25 :
|
Completed |
: The Acute Effect of Statins on Inflammatory Markers of Athersclerotic Tissue : Carotid Artery Disease : 2007-12-21 :
|
Completed |
: CHOICE: Carotid Stenting For High Surgical-Risk Patients : Carotid Artery Disease : 2006-11-29 : Device: RX ACCULINK , RX ACCUNET , XACT , EMBOSHIELD and EMBOSHIELD Nav6 Provide an ongoing post-market |
Completed |
: SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy : Carotid Artery Disease : 2006-11-20 |
Completed |
: Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT) : Carotid Artery Disease : 2006-11-20 : Device: Xact Stent with either Emboshield Pro (Gen 5) or Emboshield (Gen 3) All subjects will receive th |
Completed |
: CAPTURE 2 Post-Marketing Registry : Carotid Artery Disease : 2006-03-10 : Device: RX ACCULINK, RX ACCUNET Embolic Protection System 1) To provide an ongoing post-market surveilla |
Completed |
: Stenting and Angioplasty With Protection in Patients at High Risk for Endarterectomy (SAPPHIRE) : Carotid Artery Disease : 2005-10-03 :
|